| Drug Name: | Amineptine (57574-09-1) |
|---|---|
| PubChem ID: | 34870 |
| SMILES: | C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O |
| InchiKey: | ONNOFKFOZAJDHT-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 337.463 |
| LogP | : | 4.4993 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 49.33 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Hepatotoxicity | CYP2D6 (P10635) | CYP2D6 is associated with idiosyncratic hepatotoxicity. [ ADR Type 2 ] | Genetically determined oxidation polymorphism and drug hepatotoxicity Study of 51 patients |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|